查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1713577

2025年全球血管内血管支架市场报告

Endovascular Stent Grafts Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年血管内血管支架市场的规模将呈指数级增长。预计到 2029 年将成长至 51.9 亿美元，复合年增长率为 37.6%。预测期内的增长归因于向微创手术的持续转变、动脉粥样硬化和肺动脉栓塞等血管疾病的增加、有利的报销政策、医院数量的增加以及年轻一代糖尿病的增加。预测期内的关键趋势包括人工智慧的整合、先进成像技术的创新、针对特定患者或可定制的血管支架的开发、下一代组织工程血管移植物的开发以及技术进步。

心血管疾病盛行率的上升预计将推动未来血管内血管支架市场的成长。心血管疾病 (CVD) 包括一系列影响心臟和血管的疾病。这些疾病的盛行率不断上升，是由多种因素造成的，包括生活方式选择、医疗状况、遗传倾向和环境影响。血管内血管支架透过专注于微创手术和改善患者预后，为心血管疾病提供了有效的治疗选择。这些血管支架可加强脆弱的血管壁，防止破裂并降低危及生命的併发症的风险。例如，2023年12月，澳洲政府机构澳洲健康与福利研究所的数据显示，医生认证的心臟疾病（CHD）死亡人数从2021年的14,100人增加到2022年的14,900人。因此，心血管疾病盛行率的上升正在推动血管内血管支架市场的成长。

血管内血管支架市场的主要企业正专注于开发胸主动脉血管支架等创新产品，以提高胸主动脉瘤和夹层治疗的精确度和有效性。这些进步旨在透过先进的技术和改进的设计来改善患者的治疗效果并解决复杂的解剖挑战。胸主动脉血管支架是一种用于血管内手术治疗胸主动脉（位于胸部的主动脉部分）疾病的专用装置。它集治疗胸主动脉疾病的安全性、有效性和便利性于一体。例如，2024年2月，中国医疗设备公司心脉医疗推出多分支胸主动脉覆膜支架系统（Hector），并在瑞士首次实现临床应用。 Hector 系统代表了血管内血管支架技术的重大进步，透过保留和调整为重要器官供血的重要主动脉分支，可以治疗复杂的胸主动脉疾病。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球血管内血管支架市场 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球血管内血管支架市场：成长率分析
  • 全球血管内血管支架市场表现：规模与成长，2019-2024
  • 全球血管内血管支架市场预测：规模与成长，2024-2029，2034
  • 全球血管内血管支架总目标市场（TAM）

第六章市场区隔

  • 全球血管内血管支架市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 血液透析机通路移植物
  • 血管内血管支架
  • 冠状动脉绕道手术
  • 主动脉疾病的血管移植
  • 週边血管移植
  • 全球血管内血管支架市场（依材料、效能及预测），2019-2024 年、2024-2029 年、2034 年
  • 合成血管移植物
  • 生物血管移植
  • 混合血管移植物
  • 全球血管内血管支架市场应用、绩效及预测（2019-2024、2024-2029、2034）
  • 心臟动脉瘤
  • 肾衰竭
  • 血管闭塞
  • 冠状动脉疾病
  • 全球血管内血管支架市场：血液透析机通路移植物按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 动静脉（AV）移植物
  • 合成血液血液透析机通路移植物
  • 生物工程血液透析机通路移植物
  • 涂层血液透析机移植物
  • 血管内血液透析机移植物
  • 全球血管内血管支架市场：按类型、性能和预测对血管内血管支架进行细分，2019-2024 年、2024-2029 年、2034 年
  • 动脉瘤支架血管支架
  • 主动脉剥离血管支架
  • 胸腔血管内血管支架
  • 腹部血管内血管支架
  • 胆道血管内血管支架
  • 全球血管内支架血管支架市场：冠状动脉绕道手术手术细分（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 隐静脉移植（SVG）
  • 冠状动脉冠状动脉绕道手术
  • 血管内冠状动脉绕道手术（CABG）
  • 合成冠状动脉绕道手术手术
  • 全球血管内血管支架市场：主动脉疾病血管移植按类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 主动脉血管支架
  • 主动脉瘤移植
  • 主动脉绕道手术
  • 胸腹主动脉血管支架
  • 主动脉剥离血管支架
  • 全球血管内支架血管支架市场：週边血管移植细分市场（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 颈动脉血管支架
  • 股动脉血管支架
  • 腘动脉血管支架
  • 髂动脉支架血管支架物
  • 週边血管内血管支架

第七章 区域和国家分析

  • 全球血管内血管支架市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球血管内血管支架市场（依国家/地区、绩效及预测）2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 血管内血管支架市场：竞争格局
  • 血管内血管支架市场：公司简介
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company（BD）Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Boston Scientific Corporation
  • Terumo Corporation
  • Getinge AB
  • Cook Group Incorporated
  • Merit Medical Systems Inc.
  • Biotronik SE & Co KG
  • MicroPort Scientific Corporation
  • Endologix LLC
  • LeMaitre Vascular Inc.
  • Lifetech Scientific Corporation
  • WL Gore & Associates inc.
  • Braile Biomedica
  • BrosMed Medical BV
  • Micro Interventional Devices Inc.（MID）
  • Lombard Medical Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年血管内血管支架市场：提供新机会的国家
  • 2029年血管内血管支架市场：细分市场带来新机会
  • 2029 年血管内血管支架市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r33479

Endovascular stent grafts are medical devices used to address conditions affecting blood vessels, such as aneurysms or stenosis. They comprise a metal stent a small mesh tube covered with a fabric graft. The stent graft is introduced into the affected blood vessel via a catheter, usually inserted into a large artery in the groin or arm. These devices frequently repair aneurysms (enlarged sections of blood vessels) or other vessel damage, providing a less invasive alternative to traditional surgery.

The primary types of endovascular stent grafts include hemodialysis access grafts, endovascular stent grafts, coronary artery bypass grafts, vascular grafts for aorta diseases, and peripheral vascular grafts. Hemodialysis access grafts are specifically designed to provide an access point for hemodialysis in patients with kidney failure. Various materials, including synthetic, biological, and hybrid vascular grafts, are utilized in different applications such as cardiac aneurysms, kidney failure, vascular occlusion, and coronary artery diseases.

The endovascular stent grafts market research report is one of a series of new reports from The Business Research Company that provides endovascular stent grafts market statistics, including endovascular stent grafts industry global market size, regional shares, competitors with an endovascular stent grafts market share, detailed endovascular stent grafts market segments, market trends, and opportunities, and any further data you may need to thrive in the endovascular stent grafts industry. This endovascular stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endovascular stent grafts market size has grown exponentially in recent years. It will grow from $1.05 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 37.8%. The growth in the historic period can be attributed to rise in the incidence of aortic aneurysms, rising aging population, increasing healthcare spending in developed regions, rise in number of ambulatory surgical centers, and rising incidence of chronic disease.

The endovascular stent grafts market size is expected to see exponential growth in the next few years. It will grow to $5.19 billion in 2029 at a compound annual growth rate (CAGR) of 37.6%. The growth in the forecast period can be attributed to ongoing shift towards minimally invasive procedures, increase in vascular diseases such as atherosclerosis, and pulmonary embolism, favorable reimbursement policies, increase in number of hospitals, and increasing diabetes even in the young generation. Major trends in the forecast period include integrating artificial intelligence, innovating advanced imaging technologies, developing of patient-specific or customizable stent grafts, developing of next-generation tissue-engineered vascular grafts, and technology advancements.

The rising prevalence of cardiovascular diseases is expected to boost the growth of the endovascular stent graft market in the future. Cardiovascular disease (CVD) encompasses a range of conditions affecting the heart and blood vessels. The increasing incidence of these diseases is attributed to various factors, including lifestyle choices, medical conditions, genetic predispositions, and environmental influences. Endovascular stent grafts provide an effective treatment option for cardiovascular diseases by focusing on minimizing invasiveness and enhancing patient outcomes. These stent grafts reinforce weakened vessel walls, preventing ruptures and lowering the risk of life-threatening complications. For example, in December 2023, data from the Australian Institute of Health and Welfare, an Australian government agency, revealed that the number of doctor-certified deaths due to coronary heart disease (CHD) rose from 14,100 in 2021 to 14,900 in 2022. Consequently, the increasing prevalence of cardiovascular diseases is driving the growth of the endovascular stent graft market.

Major companies in the endovascular stent graft market are concentrating on developing innovative products, such as thoracic aortic stent-grafts, to improve the precision and effectiveness of treating thoracic aortic aneurysms and dissections. These advancements aim to enhance patient outcomes and address complex anatomical challenges through advanced technology and design enhancements. A thoracic aortic stent graft is a specialized device used in endovascular surgery to manage diseases of the thoracic aorta, which is the section of the aorta located in the chest. It provides a combination of safety, efficacy, and convenience for treating thoracic aortic conditions. For example, in February 2024, Endovastec, a China-based medical device company, launched the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and carried out its first clinical application in Switzerland. The Hector system marks a significant step forward in endovascular stent graft technology, featuring a multi-branch design that allows for the treatment of complex thoracic aortic conditions by preserving and accommodating essential aortic branches, including those supplying vital organs.

In August 2022, W. L. Gore & Associates Inc. (Gore), a US-based company specializing in a variety of medical devices, acquired InnAVasc Medical Inc. for an undisclosed sum. This acquisition was strategically intended to strengthen Gore's position in the vascular sector by incorporating InnAVasc's advanced endovascular technologies. InnAVasc Medical Inc., also a US-based firm, is known for its production of endovascular stent grafts.

Major companies operating in the endovascular stent grafts market are Cardinal Health Inc., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Terumo Corporation, Getinge AB, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc.

North America was the largest region in the endovascular stent grafts market in 2024. The regions covered in the endovascular stent grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endovascular stent grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endovascular stent grafts market consists of sales of aortoiliac stent grafts, thoracic endograft, and abdominal endografts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endovascular Stent Grafts Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endovascular stent grafts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endovascular stent grafts ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endovascular stent grafts market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Hemodialysis Access Grafts; Endovascular Stent Grafts; Coronary Artery By-Pass Grafts; Vascular Grafts for Aorta Disease; Peripheral Vascular Grafts
  • 2) By Raw Material: Synthetic Vascular Grafts; Biological Vascular Grafts; Hybrid Vascular Grafts
  • 3) By Application: Cardiac Aneurysm; Kidney Failure; Vascular Occlusion; Coronary Artery Disease
  • Subsegments:
  • 1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts; Synthetic Hemodialysis Access Grafts; Bioengineered Hemodialysis Access Grafts; Coated Hemodialysis Grafts; Endovascular Hemodialysis Grafts
  • 2) By Endovascular Stent Grafts: Aneurysm Stent Grafts; Stent Grafts For Aortic Dissection; Thoracic Endovascular Stent Grafts; Abdominal Endovascular Stent Grafts; Biliary Endovascular Stent Grafts
  • 3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG); Arterial Coronary Bypass Grafts; Endovascular Coronary Artery Bypass Grafts (CABG); Synthetic Coronary Bypass Grafts
  • 4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts; Aortic Aneurysm Grafts; Aortic Bypass Grafts; Thoracoabdominal Aortic Stent Grafts; Aortic Dissection Stent Grafts
  • 5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts; Femoral Artery Stent Grafts; Popliteal Artery Stent Grafts; Iliac Artery Stent Grafts; Peripheral Endovascular Stent Grafts
  • Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic PLC; Stryker Corporation; Becton, Dickinson and Company (BD)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endovascular Stent Grafts Market Characteristics

3. Endovascular Stent Grafts Market Trends And Strategies

4. Endovascular Stent Grafts Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Endovascular Stent Grafts Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Endovascular Stent Grafts PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Endovascular Stent Grafts Market Growth Rate Analysis
  • 5.4. Global Endovascular Stent Grafts Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Endovascular Stent Grafts Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Endovascular Stent Grafts Total Addressable Market (TAM)

6. Endovascular Stent Grafts Market Segmentation

  • 6.1. Global Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemodialysis Access Grafts
  • Endovascular Stent Grafts
  • Coronary Artery By-Pass Grafts
  • Vascular Grafts For Aorta Disease
  • Peripheral Vascular Grafts
  • 6.2. Global Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Synthetic Vascular Grafts
  • Biological Vascular Grafts
  • Hybrid Vascular Grafts
  • 6.3. Global Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Aneurysm
  • Kidney Failure
  • Vascular Occlusion
  • Coronary Artery Disease
  • 6.4. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Hemodialysis Access Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Arteriovenous (AV) Fistula Grafts
  • Synthetic Hemodialysis Access Grafts
  • Bioengineered Hemodialysis Access Grafts
  • Coated Hemodialysis Grafts
  • Endovascular Hemodialysis Grafts
  • 6.5. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Endovascular Stent Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Aneurysm Stent Grafts
  • Stent Grafts For Aortic Dissection
  • Thoracic Endovascular Stent Grafts
  • Abdominal Endovascular Stent Grafts
  • Biliary Endovascular Stent Grafts
  • 6.6. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Coronary Artery By-Pass Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Saphenous Vein Grafts (SVG)
  • Arterial Coronary Bypass Grafts
  • Endovascular Coronary Artery Bypass Grafts (CABG)
  • Synthetic Coronary Bypass Grafts
  • 6.7. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Vascular Grafts For Aorta Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endovascular Aortic Stent Grafts
  • Aortic Aneurysm Grafts
  • Aortic Bypass Grafts
  • Thoracoabdominal Aortic Stent Grafts
  • Aortic Dissection Stent Grafts
  • 6.8. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Peripheral Vascular Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Carotid Artery Stent Grafts
  • Femoral Artery Stent Grafts
  • Popliteal Artery Stent Grafts
  • Iliac Artery Stent Grafts
  • Peripheral Endovascular Stent Grafts

7. Endovascular Stent Grafts Market Regional And Country Analysis

  • 7.1. Global Endovascular Stent Grafts Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Endovascular Stent Grafts Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endovascular Stent Grafts Market

  • 8.1. Asia-Pacific Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endovascular Stent Grafts Market

  • 9.1. China Endovascular Stent Grafts Market Overview
  • 9.2. China Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endovascular Stent Grafts Market

  • 10.1. India Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endovascular Stent Grafts Market

  • 11.1. Japan Endovascular Stent Grafts Market Overview
  • 11.2. Japan Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endovascular Stent Grafts Market

  • 12.1. Australia Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endovascular Stent Grafts Market

  • 13.1. Indonesia Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endovascular Stent Grafts Market

  • 14.1. South Korea Endovascular Stent Grafts Market Overview
  • 14.2. South Korea Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endovascular Stent Grafts Market

  • 15.1. Western Europe Endovascular Stent Grafts Market Overview
  • 15.2. Western Europe Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endovascular Stent Grafts Market

  • 16.1. UK Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endovascular Stent Grafts Market

  • 17.1. Germany Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endovascular Stent Grafts Market

  • 18.1. France Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endovascular Stent Grafts Market

  • 19.1. Italy Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endovascular Stent Grafts Market

  • 20.1. Spain Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endovascular Stent Grafts Market

  • 21.1. Eastern Europe Endovascular Stent Grafts Market Overview
  • 21.2. Eastern Europe Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endovascular Stent Grafts Market

  • 22.1. Russia Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endovascular Stent Grafts Market

  • 23.1. North America Endovascular Stent Grafts Market Overview
  • 23.2. North America Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endovascular Stent Grafts Market

  • 24.1. USA Endovascular Stent Grafts Market Overview
  • 24.2. USA Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endovascular Stent Grafts Market

  • 25.1. Canada Endovascular Stent Grafts Market Overview
  • 25.2. Canada Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endovascular Stent Grafts Market

  • 26.1. South America Endovascular Stent Grafts Market Overview
  • 26.2. South America Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endovascular Stent Grafts Market

  • 27.1. Brazil Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endovascular Stent Grafts Market

  • 28.1. Middle East Endovascular Stent Grafts Market Overview
  • 28.2. Middle East Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endovascular Stent Grafts Market

  • 29.1. Africa Endovascular Stent Grafts Market Overview
  • 29.2. Africa Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endovascular Stent Grafts Market Competitive Landscape And Company Profiles

  • 30.1. Endovascular Stent Grafts Market Competitive Landscape
  • 30.2. Endovascular Stent Grafts Market Company Profiles
    • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis

31. Endovascular Stent Grafts Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Terumo Corporation
  • 31.3. Getinge AB
  • 31.4. Cook Group Incorporated
  • 31.5. Merit Medical Systems Inc.
  • 31.6. Biotronik SE & Co KG
  • 31.7. MicroPort Scientific Corporation
  • 31.8. Endologix LLC
  • 31.9. LeMaitre Vascular Inc.
  • 31.10. Lifetech Scientific Corporation
  • 31.11. W. L. Gore & Associates inc.
  • 31.12. Braile Biomedica
  • 31.13. BrosMed Medical BV
  • 31.14. Micro Interventional Devices Inc. (MID)
  • 31.15. Lombard Medical Inc.

32. Global Endovascular Stent Grafts Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endovascular Stent Grafts Market

34. Recent Developments In The Endovascular Stent Grafts Market

35. Endovascular Stent Grafts Market High Potential Countries, Segments and Strategies

  • 35.1 Endovascular Stent Grafts Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Endovascular Stent Grafts Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Endovascular Stent Grafts Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33479_Endovascular_Stent_Grafts_GMR_2025